Yan Xu
Jingqi Qi
Wei Sun
Wu Zhong1
Hongwei Wu- 1Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
- 2Zhejiang University-University of Edinburgh Institute, Haining, China
A Corrigendum on
Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma
by Xu Y, Qi J, Sun W, Zhong W and Wu H (2022). Front. Bioeng. Biotechnol. 10:897641. doi: 10.3389/fbioe.2022.897641
In the published article, there was an error in Figure 2 as published. In Figures 2C, D, an image was mistakenly duplicated. The corrected Figure 2 and its caption appear below.
Figure 2. Effect of nanoparticles on three types of normal cells and three osteosarcoma cell lines. (A) Photoscopic images of three normal cell types (HSFs, ASCs, and BMSCs) treated with 0–50 μg/mL concentrations of nanoparticles. (B) Relative cell viability of three normal cell lines under 0–50 μg/mL concentrations of nanoparticles. (C, E) Photoscopic images and relative cell viability of three kinds of osteosarcoma cells (143b, HOS, and MG63) treated with 0–10 μg/mL concentrations of nanoparticles. (D, F) Photoscopic images and relative cell viability of 143b cells treated with 0–1 μg/mL concentrations of nanoparticles. Scale bar = 100 um.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: nanoparticle, osteosarcoma, zoledronic acid, tumor therapy, targeted therapy
Citation: Xu Y, Qi J, Sun W, Zhong W and Wu H (2025) Corrigendum: Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma. Front. Bioeng. Biotechnol. 13:1601751. doi: 10.3389/fbioe.2025.1601751
Received: 28 March 2025; Accepted: 24 April 2025;
Published: 07 May 2025.
Edited and reviewed by:
Jianxun Ding, Chinese Academy of Sciences (CAS), ChinaCopyright © 2025 Xu, Qi, Sun, Zhong and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongwei Wu, d3Vob25nd2VpQGhuY2Eub3JnLmNu
†These authors have contributed equally to this work